Alexander Gutmans

Alexander Gutmans is a partner at Walder Wyss since 2014. He advises national and international clients in the fields of commercial and corporate law, mergers & acquisitions, private equity, venture capital and financings as well as in the field of health care and life sciences in contractual and regulatory matters. As a notary of the canton Basel-Stadt he accompanies his clients in commercial register and real estate register transactions as well as German notarisations.

• Nouscom AG EUR 42 Mio. Series B Financing Round: Walder Wyss advises Abingworth and 5AM Venture on Nouscom’s Series B financing round.
• BC Platforms CHF 10 Mio. B Round: Walder Wyss advises BioVersys AG, Basel, on its Extended Series A financing Round. The financing round amounts to CHF 5.5 mio. was subscribed by existing shareholders.
• BioVersys CHF 5.5 Mio. Series A Round: Walder Wyss advises BioVersys AG, Basel, on its Extended Series A financing Round. The financing round amounts to CHF 5.5 mio. was subscribed by existing shareholders.
• SHS Beteiligungs GmbH in the acquisition of evitria AG.
• FC Capital Fund I, L.P., Shanghai, in the CHF 20 Mio. financing round of Cellestia Biotech AG.

• M&A
• Venture Capital
• Life Sciences

• Accounting
• Healthcare
• Biotech
• Packaging
• Hotel
• Medtech

• Basel and Lucerne

1990: State exam; 1995: Dr. iur.; 1996: LL.M Yale Law School